Episurf Medical achieved a milestone with the planning of the 900th surgery with the Episealer® knee implant. Close to 400 patients have had the implant for more than two years, and approximately 70 patients have passed five years since surgery. Studies have shown excellent clinical improvements and a low revision rate.
“We are pleased to have reached this milestone at the end of the year. Despite a very challenging year for elective surgeries, our customers have continued to order Episealer implants when possible. We are looking forward to continued growth, supported by strong clinical evidence,” said Pål Ryfors, CEO.
Episurf Medical achieved a milestone with the planning of the 900th surgery with the Episealer® knee implant. Close to 400 patients have had the implant for more than two years, and approximately 70 patients have passed five years since surgery. Studies have shown excellent clinical improvements and a low revision rate.
“We are pleased...
Episurf Medical achieved a milestone with the planning of the 900th surgery with the Episealer® knee implant. Close to 400 patients have had the implant for more than two years, and approximately 70 patients have passed five years since surgery. Studies have shown excellent clinical improvements and a low revision rate.
“We are pleased to have reached this milestone at the end of the year. Despite a very challenging year for elective surgeries, our customers have continued to order Episealer implants when possible. We are looking forward to continued growth, supported by strong clinical evidence,” said Pål Ryfors, CEO.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.